{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Recent Developments in the Treatment of Follicular Lymphoma

Purpose of Activity

To provide information on emerging treatments in the management of patients with follicular lymphoma (FL).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

Describe novel monotherapies and combination therapies under evaluation for patients with follicular lymphoma (FL).

Price: $12.95

Credits:

  • ANCC 1.0 CH
  • DC - BON 1.0 CH
  • GA - BON 1.0 CH
  • FL - BON 1.0 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.







Test Code: OT0619
Published: June 2019
Expires: 6/4/2021
Sources: Oncology Times
Passing Score: 7/10 (70%)
Authors: Richard Simoneaux